<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Adderall XR 20 mg</title><link>http://www.unboundmedicine.com/medline/ebm/research/Adderall_XR_20_mg</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Rebound Effects with Long-Acting Amphetamine or Methylphenidate Stimulant Medication Preparations among Adolescent Male Drivers with Attention-Deficit/Hyperactivity Disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18294083/full_citation/Rebound_Effects_with_Long_Acting_Amphetamine_or_Methylphenidate_Stimulant_Medication_Preparations_among_Adolescent_Male_Drivers_with_Attention_Deficit/Hyperactivity_Disorder_</link><description>Cox DJ, Moore M, Burket R, et al. <br/><span class="title">Rebound Effects with Long-Acting Amphetamine or Methylphenidate Stimulant Medication Preparations among Adolescent Male Drivers with Attention-Deficit/Hyperactivity Disorder. [Journal Article]</span><br/><span class="source" title="Journal of child and adolescent psychopharmacology">J Child Adolesc Psychopharmacol 2008 Feb; 18(1):1-10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18294083/abstract/Rebound_Effects_with_Long_Acting_Amphetamine_or_Methylphenidate_Stimulant_Medication_Preparations_among_Adolescent_Male_Drivers_with_Attention_Deficit/Hyperactivity_Disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18294083/full_citation/Rebound_Effects_with_Long_Acting_Amphetamine_or_Methylphenidate_Stimulant_Medication_Preparations_among_Adolescent_Male_Drivers_with_Attention_Deficit/Hyperactivity_Disorder_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18294083/Rebound_Effects_with_Long_Acting_Amphetamine_or_Methylphenidate_Stimulant_Medication_Preparations_among_Adolescent_Male_Drivers_with_Attention_Deficit/Hyperactivity_Disorder_">Find Related Articles</a> </description></item><item><title>Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16750455/full_citation/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__adderall_XR__in_the_management_of_oppositional_defiant_disorder_with_or_without_comorbid_attention_deficit/hyperactivity_disorder_in_school_aged_children_and_adolescents:_A_4_week_multicenter_randomized_double_blind_parallel_group_placebo_controlled_forced_dose_escalation_study_</link><description>Spencer TJ, Abikoff HB, Connor DF, et al. <br/><span class="title">Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. [Journal Article]</span><br/><span class="source" title="Clinical therapeutics.">Clin Ther 2006 Mar; 28(3):402-18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16750455/abstract/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__adderall_XR__in_the_management_of_oppositional_defiant_disorder_with_or_without_comorbid_attention_deficit/hyperactivity_disorder_in_school_aged_children_and_adolescents:_A_4_week_multicenter_randomized_double_blind_parallel_group_placebo_controlled_forced_dose_escalation_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16750455/full_citation/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__adderall_XR__in_the_management_of_oppositional_defiant_disorder_with_or_without_comorbid_attention_deficit/hyperactivity_disorder_in_school_aged_children_and_adolescents:_A_4_week_multicenter_randomized_double_blind_parallel_group_placebo_controlled_forced_dose_escalation_study_">Full Citation</a></description></item><item><title>A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16678649/full_citation/A_post_hoc_subgroup_analysis_of_an_18_day_randomized_controlled_trial_comparing_the_tolerability_and_efficacy_of_mixed_amphetamine_salts_extended_release_and_atomoxetine_in_school_age_girls_with_attention_deficit/hyperactivity_disorder_</link><description>Biederman J, Wigal SB, Spencer TJ, et al. <br/><span class="title">A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. [Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="Clinical therapeutics.">Clin Ther 2006 Feb; 28(2):280-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16678649/abstract/A_post_hoc_subgroup_analysis_of_an_18_day_randomized_controlled_trial_comparing_the_tolerability_and_efficacy_of_mixed_amphetamine_salts_extended_release_and_atomoxetine_in_school_age_girls_with_attention_deficit/hyperactivity_disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16678649/full_citation/A_post_hoc_subgroup_analysis_of_an_18_day_randomized_controlled_trial_comparing_the_tolerability_and_efficacy_of_mixed_amphetamine_salts_extended_release_and_atomoxetine_in_school_age_girls_with_attention_deficit/hyperactivity_disorder_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0149-2918(06)00048-8">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16678649/A_post_hoc_subgroup_analysis_of_an_18_day_randomized_controlled_trial_comparing_the_tolerability_and_efficacy_of_mixed_amphetamine_salts_extended_release_and_atomoxetine_in_school_age_girls_with_attention_deficit/hyperactivity_disorder_">Find Related Articles</a> </description></item><item><title>Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16678648/full_citation/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__Adderall_XR__in_the_management_of_attention_deficit/hyperactivity_disorder_in_adolescent_patients:_a_4_week_randomized_double_blind_placebo_controlled_parallel_group_study_</link><description>Spencer TJ, Wilens TE, Biederman J, et al. <br/><span class="title">Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. [Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="Clinical therapeutics.">Clin Ther 2006 Feb; 28(2):266-79.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16678648/abstract/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__Adderall_XR__in_the_management_of_attention_deficit/hyperactivity_disorder_in_adolescent_patients:_a_4_week_randomized_double_blind_placebo_controlled_parallel_group_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16678648/full_citation/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__Adderall_XR__in_the_management_of_attention_deficit/hyperactivity_disorder_in_adolescent_patients:_a_4_week_randomized_double_blind_placebo_controlled_parallel_group_study_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0149-2918(06)00051-8">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16678648/Efficacy_and_safety_of_mixed_amphetamine_salts_extended_release__Adderall_XR__in_the_management_of_attention_deficit/hyperactivity_disorder_in_adolescent_patients:_a_4_week_randomized_double_blind_placebo_controlled_parallel_group_study_">Find Related Articles</a> </description></item><item><title>Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16344837/full_citation/Long_term_safety_and_effectiveness_of_mixed_amphetamine_salts_extended_release_in_adults_with_ADHD_</link><description>Biederman J, Spencer TJ, Wilens TE, et al. <br/><span class="title">Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. [Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="CNS spectrums.">CNS Spectr 2005 Dec; 10(12 Suppl 20):16-25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16344837/abstract/Long_term_safety_and_effectiveness_of_mixed_amphetamine_salts_extended_release_in_adults_with_ADHD_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16344837/full_citation/Long_term_safety_and_effectiveness_of_mixed_amphetamine_salts_extended_release_in_adults_with_ADHD_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16344837/Long_term_safety_and_effectiveness_of_mixed_amphetamine_salts_extended_release_in_adults_with_ADHD_">Find Related Articles</a> </description></item><item><title>Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16182674/full_citation/Short__and_long_term_cardiovascular_effects_of_mixed_amphetamine_salts_extended_release_in_children_</link><description>Findling RL, Biederman J, Wilens TE, et al. <br/><span class="title">Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="The Journal of pediatrics. ">J Pediatr 2005 Sep; 147(3):348-54.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16182674/abstract/Short__and_long_term_cardiovascular_effects_of_mixed_amphetamine_salts_extended_release_in_children_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16182674/full_citation/Short__and_long_term_cardiovascular_effects_of_mixed_amphetamine_salts_extended_release_in_children_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0022-3476(05)00206-4">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16182674/Short__and_long_term_cardiovascular_effects_of_mixed_amphetamine_salts_extended_release_in_children_">Find Related Articles</a> </description></item><item><title>Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15952928/full_citation/Safety_efficacy_and_extended_duration_of_action_of_mixed_amphetamine_salts_extended_release_capsules_for_the_treatment_of_ADHD_</link><description>Weisler RH <br/><span class="title">Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD. [Journal Article, Review]</span><br/><span class="source" title="Expert opinion on pharmacotherapy.">Expert Opin Pharmacother 2005 Jun; 6(6):1003-18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15952928/abstract/Safety_efficacy_and_extended_duration_of_action_of_mixed_amphetamine_salts_extended_release_capsules_for_the_treatment_of_ADHD_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15952928/full_citation/Safety_efficacy_and_extended_duration_of_action_of_mixed_amphetamine_salts_extended_release_capsules_for_the_treatment_of_ADHD_">Full Citation</a> | <a href="http://www.ashley-pub.com/doi/abs/10.1517/14656566.6.6.1003 http://dx.doi.org/10.1517/14656566.6.6.1003">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15952928/Safety_efficacy_and_extended_duration_of_action_of_mixed_amphetamine_salts_extended_release_capsules_for_the_treatment_of_ADHD_">Find Related Articles</a> </description></item><item><title>Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.</title><link>http://www.unboundmedicine.com/medline/ebm/record/12921476/full_citation/Pharmacokinetics_of_SLI381__ADDERALL_XR__an_extended_release_formulation_of_Adderall_</link><description>McGough JJ, Biederman J, Greenhill LL, et al. <br/><span class="title">Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="Journal of the American Academy of Child and Adolescent Psychiatry. ">J Am Acad Child Adolesc Psychiatry 2003 Jun; 42(6):684-91.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/12921476/abstract/Pharmacokinetics_of_SLI381__ADDERALL_XR__an_extended_release_formulation_of_Adderall_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/12921476/full_citation/Pharmacokinetics_of_SLI381__ADDERALL_XR__an_extended_release_formulation_of_Adderall_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0890-8567%26amp;volume=42%26amp;issue=6%26amp;spage=684">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/12921476/Pharmacokinetics_of_SLI381__ADDERALL_XR__an_extended_release_formulation_of_Adderall_">Find Related Articles</a> </description></item><item><title>Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.</title><link>http://www.unboundmedicine.com/medline/ebm/record/12921475/full_citation/Analog_classroom_assessment_of_a_once_daily_mixed_amphetamine_formulation_SLI381__Adderall_XR__in_children_with_ADHD_</link><description>McCracken JT, Biederman J, Greenhill LL, et al. <br/><span class="title">Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. [Clinical Trial, Journal Article, Randomized Controlled Trial]</span><br/><span class="source" title="Journal of the American Academy of Child and Adolescent Psychiatry. ">J Am Acad Child Adolesc Psychiatry 2003 Jun; 42(6):673-83.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/12921475/abstract/Analog_classroom_assessment_of_a_once_daily_mixed_amphetamine_formulation_SLI381__Adderall_XR__in_children_with_ADHD_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/12921475/full_citation/Analog_classroom_assessment_of_a_once_daily_mixed_amphetamine_formulation_SLI381__Adderall_XR__in_children_with_ADHD_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0890-8567%26amp;volume=42%26amp;issue=6%26amp;spage=673">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/12921475/Analog_classroom_assessment_of_a_once_daily_mixed_amphetamine_formulation_SLI381__Adderall_XR__in_children_with_ADHD_">Find Related Articles</a> </description></item><item><title>SLI-381 (Adderall XR).</title><link>http://www.unboundmedicine.com/medline/ebm/record/12828502/full_citation/SLI_381__Adderall_XR__</link><description>McKeage K, Scott LJ <br/><span class="title">SLI-381 (Adderall XR). [Journal Article]</span><br/><span class="source" title="CNS drugs. ">CNS Drugs 2003; 17(9):669-75; discussion 676-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/12828502/abstract/SLI_381__Adderall_XR__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/12828502/full_citation/SLI_381__Adderall_XR__">Full Citation</a> | <a href="http://openurl.ingenta.com/content/nlm%3fgenre=article%26amp;issn=1172-7047%26amp;volume=17%26amp;issue=9%26amp;spage=669%26amp;aulast=McKeage">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/12828502/SLI_381__Adderall_XR__">Find Related Articles</a> </description></item></channel></rss>